When Jeff Albers joined Blueprint Medicines in 2014, the private company was a clinical-stage biotech. Now, the helmsman is handing down the reins after steering the firm through an IPO and two drug ...

For decades, many ambitious young professionals have viewed landing a job on Wall Street, particularly in investment banking, as the pinnacle of success. The industry’s prestige has remained constant, ...